欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号UK/H/6705/001
药品名称Mithraring 0.120 mg/0.015 mg per 24 hours, vaginal delivery system
活性成分
    • ethinyl estradiol 0.015 mg/24 h
    • etonogestrel 0.12 mg/24 h
剂型Vaginal delivery system
上市许可持有人Mithra Pharmaceuticals S.A. Rue Saint-Georges, 5 Liège 4000 Belgium
参考成员国 - 产品名称United Kingdom (GB)
互认成员国 - 产品名称
    • Germany (DE)
      Etonogestrel/Ethinylestradiol Mithra vaginales Freisetzungssystem, 0,120 mg/0,015 mg pro 24 Stunden
    • Italy (IT)
    • Spain (ES)
    • France (FR)
    • Belgium (BE)
    • Netherlands (NL)
    • Iceland (IS)
    • Poland (PL)
      Etonogestrel/Ethinylestradiol Mithra
    • Portugal (PT)
    • Hungary (HU)
许可日期2018/06/19
最近更新日期2018/07/19
药物ATC编码
    • G02BB01 vaginal ring with progestogen and estrogen
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase